Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

304 Views

C4. Respiratory infections - viral

Poster Session: Respiratory Infections - Viral

(P-683) Estimation of RSV-attributable cardiovascular and respiratory hospitalizations in adults in Germany between 2015–2019

Thursday, October 17, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Co-Author(s)

CB

Caroline Beese, n/a

Pfizer Pharma GmbH
Berlin, Berlin, Germany

Presenting Author(s)

Caihua Liang, MD, PhD

Senior Director
Pfizer Inc
New York, New York, United States

Co-Author(s)

LB

Lea Johanna Bayer, n/a

Pfizer Pharma GmbH
Berlin, Berlin, Germany
BH

Bennet Huebbe, n/a

n.a.
Berlin, Berlin, Germany
PP

Pimnara Peerawaranun, MSc. (Statistics)

Statistician
P95
Chatuchak, Krung Thep, Thailand
RB

Robin Bruyndonckx, n/a

P95
Leuven, Brabant Wallon, Belgium
AP

Aleksandra Polkowska-Kramek, n/a

P95
Leuven, Brabant Wallon, Belgium
MC

Maribel Casas, PhD

Epidemiologist
P95
Terrassa, Catalonia, Spain
TP

Thao Mai Phuong Tran, Ph.D.

P95
Leuven, Vlaams-Brabant, Belgium
WE

Worku Biyadgie Ewnetu, n/a

P95
HASSELT, Limburg, Belgium
CV

Christof Von Eiff, n/a

Senior Medical Direktor Vaccines Germany
Pfizer Pharma gmbH
Berlin, Berlin, Germany
BG

Bradford D. Gessner, M.D., M.P.H.

Vice President Global Medical Lead for Respiratory Vaccines
Pfizer Biopharma Group
Collegeville, Pennsylvania, United States
Elizabeth Begier, MD, M.P.H.

Senior Director, Scientific Affairs Lead, RSV Antiviral/Adult Vaccine Program
Pfizer Vaccines
Dublin, Dublin, Ireland
GR

Gernot Rohde, MD

Goethe University Frankfurt
Frankfurt am Main, Hessen, Germany